Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
Clinical trial NCT05543928 · TERMINATED
Trial details
- NCT number
- NCT05543928
- Sponsor
- OPKO Health, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2024-06-19
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.